The fate of P32 labelled diisopropylfluorophosphonate in the human body and its use as a labelling agent in the study of the turnover of blood plasma and red cells.

The Journal of clinical investigation ·Vol. 33 ·No. 3 ·1954-03-00 ·Pages 459-67

COHEN JA, WARRINGA MG

Abstract

暂无摘要

Keywords

BLOOD DFP/metabolism PHOSPHORUS/radioactive

MeSH Terms

Blood Erythrocytes Human Body Humans Isoflurophate/metabolism Phosphorus Phosphorus Radioisotopes Plasma

Chemicals

Phosphorus Radioisotopes Isoflurophate Phosphorus

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

COHEN J A

WARRINGA M G

References (5)

5 references, click to expand

The half-life on homologous gamma globulin (antibody) in several species.
J Exp Med. 1952 May;95(5):313-8 PMID: 12981216
The inhibition of beta- and gamma-chymotrypsin and trypsin by diisopropyl fluorophosphate.
J Biol Chem. 1952 Feb;194(2):721-7 PMID: 14927666
Separation of the phosphoric esters on the filter paper chromatogram.
Nature. 1949 Dec 31;164(4183):1107-12, illust PMID: 15398090
Distribution of radiophosphorus in rabbit tissues after injection of phosphorus-labeled diisopropyl fluorophosphate.
J Pharmacol Exp Ther. 1950 Jan;98(1):77-84 PMID: 15403623
Mode of inhibition of chymotrypsin by diisopropyl fluorophosphate. II. Introduction of isopropyl and elimination of fluorine as hydrogen fluoride.
J Biol Chem. 1950 Jul;185(1):209-20 PMID: 15436492

Article Info

Journal

The Journal of clinical investigation

Abbr.

J Clin Invest

ISSN

0021-9738

DOI

Published

1954-03-00

Pages

459-67

Language

English

Region

United States

NLM ID

7802877

PMCID

PMC1072524

Subset

External Links

Analysis Services